Astrazeneca Pharma India Ltd Q1 FY2024-2025 Results: Summary
Revenue | ₹395.87Cr |
Net Profits | ₹-11.79Cr |
Net Profit Margins | -2.98% |
Highlights
Revenue:
Astrazeneca Pharma India Ltd’s revenue jumped 30.4% since last year same period to ₹395.87Cr in the Q1 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 1.02% jump in its revenue since last 3-months.
Net Profits:
Astrazeneca Pharma India Ltd’s net profit fell -121.89% since last year same period to ₹-11.79Cr in the Q1 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -129.86% fall in its net profits since last 3-months.
Net Profit Margins:
Astrazeneca Pharma India Ltd’s net profit margin fell -116.79% since last year same period to -2.98% in the Q1 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -129.56% fall in its net profit margins since last 3-months.
